Clinical trial
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment…
NCT00315276 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00315276 |
|---|---|
| Title | Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD |
| Official title | A 9-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With Attention Deficit/Hyperactivity Disorder |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder, ADHD |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 370 |
| Start date | May 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Apr 18, 2006 |
| Last update posted | Aug 24, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: